Guardant Health
GH
#1156
Rank
C$28.13 B
Marketcap
C$207.98
Share price
1.30%
Change (1 day)
55.61%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: C$28.13 Billion

As of November 2026 Guardant Health has a market cap of C$28.13 Billion. This makes Guardant Health the world's 1156th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026C$28.13 B53.62%
2025C$18.31 B239.37%
2024C$5.39 B23.93%
2023C$4.35 B15.18%
2022C$3.78 B-70.82%
2021C$12.95 B-21.12%
2020C$16.42 B71.42%
2019C$9.58 B118.25%
2018C$4.39 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Guardant Health was reported to be:

C$28.13 Billion
by Nasdaq info icon info icon
C$28.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
C$3.46 B-87.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C$60.15 B 113.79%๐Ÿ‡บ๐Ÿ‡ธ USA